-
1
المؤلفون: Guangdi Li, Erik De Clercq
المصدر: Antiviral Research
مصطلحات موضوعية: 0301 basic medicine, Oncology, Time Factors, GT, genotype, IC50, half maximal inhibitory concentration, Hepacivirus, Pharmacology, Viral Nonstructural Proteins, Direct-acting antivirals, Efficacy, 0302 clinical medicine, Interferon, Drug Discovery, Medicine, QD, once a day, CDC, Centers for Disease Control and Prevention, Drug discovery, NS3/4A drugs, HIV, human immunodeficiency virus, Drug development, Pill, HCV, hepatitis C virus, EC50, half maximal effective concentration, FDA, U S Food and Drug Administration, 030211 gastroenterology & hepatology, Drug Therapy, Combination, medicine.drug, medicine.medical_specialty, RBV, ribavirin, SVR12, sustained virologic response after the treatment for 12 weeks, Genotype, PegIFNα, pegylated interferon alfa, Antiviral Agents, Virus, Article, WHO, World Health Organization, 03 medical and health sciences, Viral Proteins, TID, three times a day, Virology, Internal medicine, SVR24, sustained virologic response after the treatment for 24 weeks, Potency, Humans, BID, twice a day, NS5A drugs, business.industry, DAA, direct-acting antiviral, Hepatitis C, Chronic, Clinical trial, 030104 developmental biology, HBV, hepatitis B virus, NS5B drugs, Interferons, Serine Proteases, business, HCC, hepatocellular carcinoma
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.
